Advertisement

Topics

Augmenix, Inc. Company Profile

00:00 EDT 20th September 2017 | BioPortfolio

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or efficacy. Augmenix's first product, SpaceOAR system is an injectable tissue spacer that will decrease rectal morbidity or enable improved efficacy in prostate radiotherapy. The company was founded in 2008.


News Articles [14 Associated News Articles listed on BioPortfolio]

Augmenix Release: SpaceOAR System Receives Shonin Approval In Japan

Advanced hydrogel technology from Augmenix used during prostate cancer radiation therapy now available to cancer treatment centers in Japan. BEDFORD, Mass.--(BUSINESS WIRE)--Augme...

Augmenix's SpaceOAR system wins approval in Japan

The Japanese Ministry of Health, Labor and Welfare has given Augmenix Shonin approval for its SpaceOAR system.  -More- 

Augmenix Announces First Prostate Cancer Patients Treated With Spaceoar Hydrogel In Israel

  Life Sciences Jobs   ...

Augmenix Release: NICE Announces Interventional Procedure Guidance Supporting Use Of Hydrogel Spacer In Treatment Of Prostate Cancer In The UK

  Life Sciences Jobs   ...

Augmenix Announces Positive Five-Year Long-Term Data Highlighting Significant Bowel And Sexual Quality Of Life Benefits For Prostate Cancer Patients Treated With Spaceoar Hydrogel

  Life Sciences Jobs   ...

Augmenix Ranked as One of America’s Fastest-Growing Private Companies for Second Year

Augmenix Maintains Spot in Top 10% of Metro-Boston Companies; Three-Year Growth over 2,000% Ranked Company Number 207 on Inc. Magazine’s Top 500 Augmenix, Inc....

Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel

Augmenix, Inc., a medical technology company that develops, manufactures and sells absorbable hydrogels that separate and protect organs at risk during radiotherapy, today announc...

SpaceOAR® System Receives Shonin Approval in Japan

Advanced hydrogel technology from Augmenix used during prostate cancer radiation therapy now available to cancer treatment centers in Japan. Augmenix, Inc., a medical t...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Augmenix, Inc.

Augmenix, Inc. is a privately held company based in Waltham, Mass., focused on the development and commercialization of implantable biomaterial based solutions for improved radiotherapy safety and/or ...

Augmenix Inc.

More Information about "Augmenix, Inc." on BioPortfolio

We have published hundreds of Augmenix, Inc. news stories on BioPortfolio along with dozens of Augmenix, Inc. Clinical Trials and PubMed Articles about Augmenix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Augmenix, Inc. Companies in our database. You can also find out about relevant Augmenix, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biomaterial
A biomaterial is defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic proc...


Corporate Database Quicklinks



Searches Linking to this Company Record